Next, check out my gal Holly’s post about the process of reintroducing foods after completing a Whole30. As she reminds us, it’s important not to just go crazy on Day 31. Instead, “[e]xperiment with foods you miss, but do it in a way that will actually help you gather more information.” The Whole30 website also has a great post on what to do when your Whole30 is finished here.
The "CrossFit Games", directed by Dave Castro, have been held every summer since 2007. Athletes at the Games compete in workouts they learn about only hours beforehand, sometimes including surprise elements that are not part of the typical CrossFit regimen. Past examples include a rough-water swim, a softball throw, and a pegboard climb. The Games are styled as a venue for determining the "Fittest on Earth," where competitors should be "ready for anything."
To the outside world, though, as Glassman's company has exploded from a cult fitness website to a gym concept primed to have more locations than Curves by the end of 2013, CrossFit can appear risky, unhinged: Here is a fitness routine that has sent people to the hospital, overseen by people who may have had no more than two days of instruction. (Although every real trainer I met had considerable experience and was genuinely excellent, I attended the seminar and passed the test on my fourth day reporting this story. I am, believe me, no fitness savant.) And it's all led by a man who, in a 2006 CrossFit.com comment, wrote, "We have a therapy for injuries at CrossFit called STFU." As in, Shut the f-k up. That's enough to make even the most devoted laissez faire-ists get a little, well, Uncle Pukie.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”